Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Sevilla

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 5, 2024
Lifecycle model-based evaluation of infant 4CMenB vaccination in the UKJ P Sevilla, Daniel Tortorice, David Kantor, et al.
BMJ Global Health|September 7, 2024
The global health and economic value of COVID-19 vaccinationJ P Sevilla, Daria Burnes, Joseph S Knee, et al.
Journal of Medical Economics|August 19, 2022
Cost-utility and cost-benefit analysis of TAVR availability in the US severe symptomatic aortic stenosis patient populationJ P Sevilla, Jessica M Klusty, Younghwan Song, et al.
BMJ Global Health|June 22, 2026
Health and economic burdens of emerging infectious diseases in the USA, US territories and globallyJ P Sevilla, Daria Burnes, Mona Birjandi, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 5, 2024
Lifecycle model-based evaluation of infant 4CMenB vaccination in the UKJ P Sevilla, Daniel Tortorice, David Kantor, et al.
BMJ Global Health|September 7, 2024
The global health and economic value of COVID-19 vaccinationJ P Sevilla, Daria Burnes, Joseph S Knee, et al.
Journal of Medical Economics|August 19, 2022
Cost-utility and cost-benefit analysis of TAVR availability in the US severe symptomatic aortic stenosis patient populationJ P Sevilla, Jessica M Klusty, Younghwan Song, et al.
BMJ Global Health|June 22, 2026
Health and economic burdens of emerging infectious diseases in the USA, US territories and globallyJ P Sevilla, Daria Burnes, Mona Birjandi, et al.
Pageof 2